George Washington's Vaccine Research Unit is participating in the Project NextGen clinical study. Read this article on the journey to preparing the vaccines and treatments for the next outbreak.
Project NextGen — Defeating SARS-CoV-2 and Preparing for the Next Pandemic
Latest News
Study Highlights Need for Defined Markers of Mpox Immunity to Inform Public Health Use
Read more information about how The George Washington Vaccine Research Unit is looking for adolescents between the ages of 12 and 17 to participate in a Mpox vaccine trial. The need for adolescents is vital for researchers to get an approved vaccine for adolescents to prevent another outbreak.
Read more about the new hope found in Phase 1 clinical trials for the HIV vaccine.